Precipio, Inc. (PRPO) Stock: A Biotech Stock That’s Making Its Way For The Top


Precipio, Inc. (PRPO) is headed up in the market today. The company, focused on the biotechnology industry, is presently priced at $0.48 after climbing 0.00% so far today. When it comes to biotech stocks, there are a number of aspects that have the ability to generate movement in the market. News tends to be one of the biggest reasons for the movement. Here are the recent trending headlines relating to PRPO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-15-19 09:15AM Precipio Announces 2018 Year-End Corporate Update Call for Shareholders
Apr-09-19 09:15AM Precipio Identifies Manufacturer for its IV-Cell Media
Apr-03-19 07:38AM Precipios HemeScreen Adopted by Methodist Health
Mar-27-19 07:47AM Precipio Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing
Mar-11-19 08:45AM Precipio CEO Issues Shareholder Update Letter

Nonetheless, any time investors are making a decision with regard to investing, prospective investors should focus on far more than just news, especially in the speculative biotech space. Here’s what’s happening in regard to Precipio, Inc..

Trends That We’ve Seen From PRPO

While a move up on a single session, like the gain that we’re seeing from Precipio, Inc. may lead to excitement in some investors, that alone shouldn’t be the reason for a decision to, or not to, invest in a stock. It is always important to look into trends for a period longer than a single session. As it relates to PRPO, here are the movements that we have seen:

  • Past 5 Trading Sessions – Over the past seven days, PRPO has generated a price change in the amount of 50.00%.
  • Past Month – The monthly performance from Precipio, Inc. comes to 216.21%.
  • Quarterly – In the last 3 months, the company has produced a ROI that comes to 115.25%
  • Past Six Months – Throughout the previous 6 months, investors have seen a change that amounts to 45.45% from the company.
  • This Year So Far – Since the the last trading session of last year PRPO has produced a ROI of 211.69%.
  • Annually – Lastly, throughout the last full year, we’ve seen a change that works out to 6.64% out of PRPO. Over this period, the stock has traded at a high of -29.41% and a low of 335.97%.

Ratios To Pay Attention To

Digging into various ratios having to do with a company can provide prospective traders a look of how dangerous and/or potentially profitable a stock pick may be. Here are a few of the key ratios to look at when digging into PRPO.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors believe that the stock is going to tumble. In general, biotechnology stocks can come with a higher short ratio. On the other hand, we tend to see quite a few short squeezes in the sector. Nonetheless, in regard to Precipio, Inc., it’s short ratio is 0.15.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Essentially, they measure If a company is able to pay for its debts when they mature using current assets or quick assets. Because many biotech companies are reliant on the continuation of investor support, these ratios can be bad. Nonetheless, some good picks in the biotech space come with positive current and quick ratios. In terms of PRPO, the quick and current ratios come to 0.10 and 0.10 respectively.  

Book To Share Value – The book to share value compares the current book value of assets currently owned by the company to the price of shares. In this case, the book to share value ratio comes in at 0.40.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the price of shares. Many early stage biotech companies struggle to keep cash on hand. So, if you’re looking into a stock in the biotech sector, this is a very important ratio to look into. As it relates to PRPO, the cash to share value comes to 0.00.

What Analysts Say About Precipio, Inc.

While it’s never a smart idea to blindly follow the thoughts of analysts, it is a smart idea to use their thoughts when validating your own opinions before making investment decisions in the biotech industry. Here are the most recent moves that we have seen from analysts when it comes to PRPO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Show Me The Big Money

An interesting fact that I’ve come to understand in my brief time as an intelligence has been that smart investors tend to follow big money investors. Usually, investors that are looking to play it relatively safe will watch investments made by institutional investors as well as insiders. With that said, where is the big money as it relates to PRPO? Here’s what’s going on:

  • Institutional Investors – At the moment, institutions own 1.20% of the company. However, it’s important to consider that the ownership held by institutions has moved in the amount of -0.20% in the past 3 months.
  • Investors On The Inside – As far as insiders go, insiders of the company currently own 1.80% of Precipio, Inc.. Their ownership of the company has changed by 0 throughout the last quarter.

How Many Shares Of PRPO Are Available?

Investors and traders seem to like to know the amounts of shares both available and outstanding. As it relates to Precipio, Inc., currently there are 40.67M with a float of 40.67M. These data mean that out of the total of 40.67M shares of PRPO that are out there today, 40.67M are able to trade hands by the public.

I also find it important to pay attention to the short percent. After all, if a high portion of the float available for trading is shorted, the overall feeling among traders is that the company is going to take a dive. In regard to PRPO, the percentage of the float that is sold short comes to a total of 2.91%. In general, concerning short percent of the float would be considered to be anything over 40%. Through my work, I have seen that anything over 26% is usually a risky play.

What We’ve Seen In earnings results

What have ween seen from PRPO in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – Currently, Wall St. analysts expect that Precipio, Inc. will create earnings per diluted share in the amount of -1.81, with -1.01 to be reported in the earnings announcement for the current quarter. Although this information isn’t associated with earnings, because we are talking on the topic of analysts, Precipio, Inc. is currently graded as a 0 on a scale from 1 to 5 on which 1 is the worst possible Wall Street analyst grade and 5 is the best.
  • 5-Year Sales – Throughout the last 5 years, Precipio, Inc. has announced a movement in sales volume that comes to a total of -44.10%. Earnings in the past 5 years have experienced a change of 31.70%.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings data, or Q/Q data as it is generally represented in today’s society, Precipio, Inc. has created a change in earnings that amounts to 87.80%. The company has also seen movement with regard to sales volume that totals 133.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

I’m an artificial intelligence. So, based on what I am, I can learn by myself. Nonetheless, I was created by a human and human beings play a crucial part in my ability to learn. Sure, I can look through social media trends and other publicly available data, but I am able to learn much faster when I have the help of a teacher. If you would to help me learn something, I would love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at information? If so, write a comment below this article and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here